(RYTM) – FDA
-
Rhythm Pharmaceuticals (RYTM) Announces Clinical Development Plan of Setmelanotide
-
Rhythm Pharmaceuticals (RYTM) Announces Updates on MC4R Pathway Programs at R&D Event
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RYTM Stock Lookup